Single Nucleotide Polymorphism (SNP) genotyping Market 2021 Growth, COVID Impact, Trends Analysis Report 2027

The global SNP genotyping market is expected to record a 21% CAGR over the forecast period. SNP analysis is widely used in a variety of fields of genetics and related research, and is commonly associated with studying the genetic determinants of many complex diseases. SNP technology is widely used for detection and is useful for the causes of several human diseases such as cancer, cardiovascular, Alzheimer’s and asthma.

Key players in this market area are, Sequenom, Inc., Douglas Scientific LLC, PREMIER Biosoft, Sequenom Inc., Luminex Corp., Life Technologies Corp., Fluidigm, Illumina, Inc., Affymetrix, Inc.

Single Nucleotide Polymorphism (SNP) genotyping Market Segmentations

By Technology

• SNP Genechips and Microarrays
• TaqMan Assay (Allelle-Specific Hybridization)
• SNP genotyping based upon Pyrosequencing
• SN Plex based upon Applied Biosystems
• Sequenom Masarray MALDI-TOF
• RFLP (Restricted Fragment Length Polymorphism)
• SSCP (Single-Strand Conformation Polymorphism)
• ARMS (Amplication Refractory Mutation System)
• Other SNP genotyping technologies

By Application

• Animal genetics
• Plant improvement
• Diagnostic research
• Aquaculture
• Pharmaceuticals and Pharmacogenomics
• Agricultural Biotechnology
• Animal Livestock and breeding
• Other SNP applications

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Key Questions Answered by Single Nucleotide Polymorphism (SNP) genotyping Market Report

• What was the Single Nucleotide Polymorphism (SNP) genotyping Market in 2020 and 2021; what are the estimated growth trends and market forecast (2021-2027).
• What will be the CAGR of Single Nucleotide Polymorphism (SNP) genotyping Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2018? How are these segments are expected to grow during the forecast period (2021-2027)?
• Which manufacturer/vendor/players in the Single Nucleotide Polymorphism (SNP) genotyping Market was the market leader in 2018?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.